Orgenesis Inc. (ORGS)
OTCMKTS
· Delayed Price · Currency is USD
2.000
+0.050 (2.56%)
May 13, 2025, 11:15 AM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Therapies | 515.00K |
Log In |
Log In |
Log In |
Log In |
| Therapies Growth | -91.99% |
Log In |
Log In |
Log In |
Log In |
| Octomera | 68.00K |
Log In |
Log In |
Log In |
Log In |
| Octomera Growth | -99.81% |
Log In |
Log In |
Log In |
Log In |
| Eliminations | -53.00K |
Log In |
Log In |
Log In |
Log In |
| Eliminations Growth | -99.05% |
Log In |
Log In |
Log In |
Log In |
| Point-of-Care and Hospital Services | - |
Log In |
Log In |
Log In |
Log In |
| Point-of-Care and Hospital Services Growth | - |
Log In |
Log In |
Log In |
Log In |
| Cell Process Development Services | - |
Log In |
Log In |
Log In |
Log In |
| Cell Process Development Services Growth | - |
Log In |
Log In |
Log In |
Log In |
| Contract Development and Manufacturing Organization | - |
Log In |
Log In |
Log In |
Log In |
| Contract Development and Manufacturing Organization Growth | - |
Log In |
Log In |
Log In |
Log In |
| Point-of-Care Cell Therapy Services | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Belgium | 530.00K |
Log In |
Log In |
Log In |
Log In |
| Belgium Growth | -98.53% |
Log In |
Log In |
Log In |
Log In |